United States · FDA National Drug Code directory
Naproxen Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 41250-225_45c5dfca-97dc-cb72-e063-6294a90a8f98
- Product NDC
- 41250-225
- Form
- CAPSULE, LIQUID FILLED
- Composition / generic term
- Naproxen Sodium
- Labeler
- MEIJER DISTRIBUTION INC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190201
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (41250-225-15) / 40 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 41250-225-15
- 1 BOTTLE, PLASTIC in 1 CARTON (41250-225-16) / 50 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 41250-225-16
- 1 BOTTLE, PLASTIC in 1 CARTON (41250-225-78) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC · 41250-225-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →